Core Cap Advisors, LLC Seelos Therapeutics, Inc. Transaction History

Core Cap Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.66 - $259.46 $66 - $25,945	100 New	100 $0
Q2 2022 Aug 11, 2022	BUY	$0.51 - $0.93 $51 - $93	100 New	100 $0
Q1 2022 Apr 29, 2022	SELL	$0.84 - $1.71 $84 - $171	-100 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$1.59 - $2.38 $159 - $238	100 New	100 $1,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.